Download PDF
Semin Neurol 2008; 28(3): 389
DOI: 10.1055/s-0028-1082952
ERRATA

© Thieme Medical Publishers

erratum “Current Evidence and Therapeutic Strategies for Multiple Sclerosis”

Dean M. Wingerchuk1
  • 1Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, Arizona
Further Information

Publication History

Publication Date:
24 July 2008 (online)

   Permissions and Reprints

The publisher regrets an error in the text of the above article in Seminars in Neurology, Volume 28, Number 1, 2008, p. 65. In the last paragraph, at the bottom of the first column, the text reads as follows:

Progressive multifocal leukoencephalopathy has also emerged in association with rituximab therapy for rheumatoid arthritis, typically in patients exposed to other immunosuppressive agents.86

The corrected text should read as follows:

Progressive multifocal leukoencephalopathy has also emerged in association with rituximab therapy for systemic lupus erythematosus, typically in patients exposed to other immunosuppressive agents.86

Dean M WingerchukM.D. M.Sc. F.R.C.P.(C.) 

Department of Neurology, Mayo Clinic College of Medicine

13400 E Shea Boulevard, Scottsdale, AZ 85259

Email: wingerchuk.dean@mayo.edu

      >